The course of diabetic retinopathy following extracapsular cataract extraction with posterior chamber lens implantation in eyes previously treated by laser photocoagulation for diabetic retinopathy was retrospectively studied in 33 eyes (33 patients). In 20 eyes (61%) there was no change in the retinal status postoperatively. In 13 (39%) there was postoperative progression of diabetic retinopathy compared with the fellow non-operated eye, in which progression occurred in nine eyes (27%). The severity of the preoperative status affected the incidence of progression. Four eyes (12%) developed complications ofdiabetic retinopathy -that is, rubeosis iridis and vitreous haemorrhage -which regressed after lasering. Cystoid macular oedema developed in 13 eyes (39%) and its incidence varied according to the postoperative course of diabetic retinopathy. The majority of the eyes showed a postoperative improvement in vision. 
A number of studies have shown that diabetic retinopathy may progress after cataract extraction.'1-In our earlier study of the course of diabetic retinopathy following cataract extraction we found that the preoperative presence of diabetic retinopathy is a risk factor for its postoperative progression.'0 Excluded from that study however were eyes that, prior to surgery, had received laser treatment for established diabetic retinopathy. It was of interest to find out whether the preoperative laser treatment in those eyes had affected the postoperative course of diabetic retinopathy. In order to address this question we retrospectively reviewed the course of diabetic retinopathy in diabetic eyes that underwent extracapsular cataract extraction and in which the retinopathy had been treated by laser treatment at least 3 months prior to the cataract surgery.
Patients and methods
The records of all diabetic patients who underwent extracapsular cataract extraction with posterior chamber intraocular lens implantation in our department between the years 1984 and 1990 were reviewed. Included in this study were 33 eyes of33 patients who met the following criteria: (1) diabetes mellitus diagnosed at least 6 months prior to cataract surgery; (2) Of the 13 eyes with postoperative progression of diabetic retinopathy seven had NPDR and six had PDR. Among the former group progression of retinopathy occurred in five eyes in the Fl period, in one eye in the F2 period, and in one eye in the F3 period. In the latter group progression occurred in one eye in the Fl period, in three eyes in the F2 period, and in two eyes in the F3 period.
Of 13 eyes with postoperative evidence of progression of diabetic retinopathy, 10 received additional laser treatment within 1 year ofcataract surgery, because of the following indications: retinal neovascularisation (two eyes), rubeosis iridis (one eye), vitreous haemorrhage (one eye), rubeosis iridis and vitreous haemorrhage (one eye) and aggravation of NPDR (five eyes). Following laser treatment the five eyes with PDR showed resorption of vitreous haemorrhage and regression of rubeosis iridis and retinal neovascularisation. In the other five eyes with NPDR one eye showed an improvement in the retinal status, three showed no further changes, and one showed further progression of the retinopathy in spite of treatment. Three eyes were not treated; in two of them (with NPDR) the retinopathy remained stable and in one eye (with PDR) it deteriorated with development of vitreous haemorrhage towards the end of the 1 year period of follow-up. The latter was treated successfully after the end of the 1 year period of follow-up.
Good visual acuity of 6/12 or better was achieved in only 24% of the study group (Table  2) . However, a comparison between the pre-and postoperative visual acuity revealed that the majority of eyes showed at least some improvement (Fig 1) . The most frequent cause of the low visual acuity was the presence ofCMO (Table 3) .
Follow-up of the 33 non-operated fellow eyes over 1 year revealed no change in the retinal status of 24 (73%) of them and progression of diabetic retinopathy in nine (27%). Among the former group retinopathy remained unchanged in 17 of the fellow operated eyes (7 1%) and progressed in seven (29%). Among the latter group retinopathy progressed in six of the fellow operated eyes (66 6%) and remained unchanged in three (33 3%). A symmetric course was seen in 23 patients (70%).
Discussion
Postoperative progression ofdiabetic retinopathy occurred in 39% of the eyes in this series. This rate is similar to that in diabetic eyes that underwent the same surgical procedure but did not receive laser treatment prior to surgery (38%),'°and is slightly higher than that among the fellow non-operated eyes (27%). Furthermore when we examined the state of retinopathy in non-operated eyes in relation to the postoperative course in the fellow operated eyes we found that where the operated eye showed no change in retinal status the non-operated eye tended also to remain unchanged (71%), while if the operated eye showed progression there was a tendency to progression in the non-operated eye as well (66 6%).
Ruiz and Saatci also found progression of Pollack, Leiba, Bukelman, Abrahami, Oliver (2) the course of progression in many of the nonoperated eyes resembled that in the operated fellow eye; (3) the rate of postoperative progression in eyes treated with laser for advanced preoperative diabetic retinopathy was similar to that in eyes with mild diabetic retinopathy.'0 The overall incidence of postoperative progression of diabetic retinopathy was 39%. The rate varied however according to the preoperative severity of the retinopathy, from 32% (7/22) in eyes with preoperative NPDR to 55% (6/11) in eyes with preoperative PDR. This is in line with previous observations that the postoperative prognosis of diabetic retinopathy depends on its In three eyes they disappeared again after additional laser treatment during the year of followup; in the fourth, vitreous haemorrhage appeared towards the end of the study period and its outcome is therefore not recorded here. The inclusion of eyes with advanced diabetic retinopathy may explain the occurrence of complications in this group in spite of preoperative lasering, especially the development of rubeosis iridis in two eyes. In a previously described nonlasered group'0 these complications, although expected, did not occur even though that seriesunlike the present one -included eyes that underwent intracapsular cataract extraction considered as a risk factor for development of rubeosis.4213 On the other hand the diabetic retinopathy in those eyes was less advanced on average than in the present series.
Visual acuity of at least 6/12 was achieved in 24% of our patients, and an additional 24% achieved vision between 6/15 and 6/30. In eyes with severe diabetic retinopathy, and especially in those with maculopathy, improvement in vision may be a more relevant criterion ofsuccess than the final visual acuity. As shown in Figure 1 a majority of eyes showed improvement in vision postoperatively even though many of these eyes had advanced diabetic retinopathy and CMO occurred frequently (Table 3) .
The results of this study indicate that in eyes with advanced diabetic retinopathy laser treatment applied at least 3 months prior to cataract surgery may stabilise the retinopathy but does not prevent its postoperative progression. The question then arises: should patients with cataract but with adequate fundus visualisation receive laser treatment even when the diabetic retinopathy is not severe enough to meet the criteria for laser treatment outlined by the Diabetic Retinopathy Multicentre Studies? Until this issue is tested in randomised clinical trials we suggest that these patients be closely followed after cataract surgery and any progression of their retinopathy be treated promptly.
